Why Scientists Are Revisiting a Polarizer

• by Rachana Pradhan

• February 10, 2026

Does Structured Reporting Improve Lung Cancer Reports?

A structured reporting tool improved report completeness, reduced classification errors, and achieved high physician adoption during routine lung cancer pathology reporting.

• by Andrea Surnit

• July 2, 2026

• 3 min

FDA Grants Traditional Approval to Iptacopan in Primary IgAN

Novartis reported less annual eGFR decline with iptacopan than placebo over 2 years in the phase 3 APPLAUSE-IgAN trial.

• by Kathryn Wighton

• July 17, 2026

• 2 min

Can LAI-CAB Sustain Long-Term PrEP Use?

A national claims analysis found modest uptake and declining persistence over 2 years despite increasing use of injectable HIV pre-exposure prophylaxis.

• by Andrea Surnit

• July 17, 2026

• 4 min